KDM5B and pancreatic neoplasm: For pancreatic cancer, Li et al. analyzed bioinformatically that lysine demethylase 5B (KDM5B) was increased in the tumor part and contributed to immunologically cold tumor microenvironment in respect of CD8+ T cell and interferon γ and validated with a subcutaneous mouse model [90].